首页> 外文期刊>Disease Management >Treatment Effects Model for Assessing Disease Management: Measuring Outcomes and Strengthening Program Management
【24h】

Treatment Effects Model for Assessing Disease Management: Measuring Outcomes and Strengthening Program Management

机译:评估疾病管理的治疗效果模型:衡量结果并加强计划管理

获取原文
获取原文并翻译 | 示例
           

摘要

This paper describes an analytical methodology for obtaining statistically unbiased outcomes estimates for programs in which participation decisions may be correlated with variables that impact outcomes. This methodology is particularly useful for intraorganizational program evaluations conducted for business purposes. In this situation, data is likely to be available for a population of managed care members who are eligible to participate in a disease management (DM) program, with some electing to participate while others eschew the opportunity. The most pragmatic analytical strategy for in-house evaluation of such programs is likely to be the pre-intervention/post-intervention design in which the control group consists of people who were invited to participate in the DM program, but declined the invitation. Regression estimates of program impacts may be statistically biased if factors that impact participation decisions are correlated with outcomes measures. This paper describes an econometric procedure, the Treatment Effects model, developed to produce statistically unbiased estimates of program impacts in this type of situation. Two equations are estimated to (a) estimate the impacts of patient characteristics on decisions to participate in the program, and then (b) use this information to produce a statistically unbiased estimate of the impact of program participation on outcomes. This methodology is well-established in economics and econometrics, but has not been widely applied in the DM outcomes measurement literature; hence, this paper focuses on one illustrative application.
机译:本文介绍了一种分析方法,可为计划获得统计上无偏见的结果估计,其中参与决策可能与影响结果的变量相关。此方法对于出于业务目的进行的组织内计划评估特别有用。在这种情况下,有资格参加疾病管理(DM)计划的管理型护理人员群体可能会获得数据,其中一些人选择参加,而另一些人则放弃机会。对此类程序进行内部评估的最实用的分析策略可能是干预前/干预后设计,其中对照组由被邀请参加DM计划的人员组成,但拒绝了邀请。如果影响参与决策的因素与成果指标相关,则对计划影响的回归估计可能会产生统计偏差。本文介绍了一种计量经济程序,即“治疗效果”模型,该模型的开发目的是在这种情况下产生对计划影响的统计无偏估计。估计了两个方程,以(a)评估患者特征对参加该计划的决策的影响,然后(b)使用此信息对计划参与对结果的影响进行统计上无偏的估计。这种方法在经济学和计量经济学中已经很成熟,但是在DM结果测量文献中并未得到广泛应用。因此,本文着重于一个说明性应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号